Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally. It engages in the development of Somatuline for neuroendocrine tumors and acromegaly indications; and Dysport for motor muscular disorders and medical aesthetics indications; and Decapeptyl for advanced metastatic prostate cancer, uterine fibroids, central precocious puberty, endometriosis, female infertility, and e...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 33 1 58 33 50 00
Fax: 33 1 58 33 50 01
Address:
70 rue Balard, Paris, France
